HealthTronics renews proposal to completely acquire Endocare
Friday, 5 Septerber 2008 - HealthTronics, Inc. renewed his intention to acquire all of the outstanding shares of Endocare’s common stock for $2.28 per share. James Whittenburg, President and Chief Executive Officer of HealthTronics wrote a letter to the Endocare, Inc. Board of Directors to reaffirm its proposal....
First robot-assisted surgery to repair a rare type of hernia
Wednesday, 3 September 2008 - For the first time Prof. Ashok K. Hemal, a urologist at Wake Forest University Baptist Medical Center, repaired a rare type of hernia using robot-assisted, minimally invasive surgery. The surgery required only an 18-hour hospital stay; typically, the repair involves major surgery and...
University dismissed rector in Austrian stem-cell scandal
Monday, 1 September 2008 - The scandal of the disputed stem cell study at the university of Innsbruck in Austria has a first sacrifice. Prof. Clemens Sorg, German immunologist and rector of the Medical University of Innsbruck, has been dismissed without notice due to a "serious breach of his...
Lawyer of Austrian doctor denies irregularities in stem cell therapy case
Wednesday, 20 August 2008 - The lawyer of an Austrian urologist has told a UK-based science magazine that his client has not violated Austrian law in a case that involved the use of a novel stem cell therapy for patients with incontinence problems. The case attracted media attention following statements...
Procedural problems in stem cell and incontinence research
Tuesday, 19 August 2008 - Austrian health authorities said clinical trials conducted by researchers at a medical school in Austria were marred with procedural and ethical irregularities.
Austria’s Agency for Health and Food Safety reported that clinical trails on stem cell and incontinence research led by...
Suicide rates among cancer patients in the US
Monday, 18 August 2008 - Cancer patients are nearly twice as likely as the U.S. general population to commit suicide, according to a study by researchers at the University of Washington. The study (Misono S, et al. University of Washington, Seattle, WA.) compared suicide rates among people diagnosed with cancer in the...
Progression of prostate cancer: Multiple pathways to androgen independence
Friday, 15 August 2008 - Prostate cancer remains one of the most commonly diagnosed cancers and a leading cause of cancer death in men. Initially, prostate tumors respond to hormonal therapies, but androgen-independent tumors refractory to these therapies emerge. Identifying the mechanisms responsible for the...
Analysis of T1c prostate cancers treated at very low prostate-specific antigen levels
Wednesday, 13 August 2008 - The Prostate Cancer Prevention Trial (PCPT) has challenged the validity of recommended prostate-specific antigen (PSA) thresholds for prostate biopsy (>2.5ng/ml) given the 17% prostate cancer (pCA) detection rate at PSA of 1.1-2.0. The outcome of patients treated at PSA < /=2.5 is...
Diagnostic accuracy of extended biopsies for the staging of microfocal prostate cancers in autopsy specimen
Thursday, 7 August 2008 - Clinically insignificant prostate cancers may be predicted when biopsies show a microfocal cancer (MiFC). However, at least one-third of MiFC are underestimated by biopsies. Delongchamps et al. (2008) evaluated the staging accuracy of different biopsy regimen showing a MiFC.
The authors...
Imaging of urinary tract tumors
Wednesday, 6 August 2008 - Imaging has an important role in the evaluation of patients with invasive bladder cancer. It is useful in staging of bladder cancer, despite having some limitations. Computed tomography (CT) is widely accessible and has enjoyed rapid advances in multidetector technology with far-reaching...










